Negara: Australia
Bahasa: Inggris
Sumber: Department of Health (Therapeutic Goods Administration)
Agalsidase alfa
Shire Australia Pty Ltd
Medicine Registered
_Consumer Medicine Information _ _ _ _REPLAGAL_ _®_ _ _ _ _ _Page _ _1 _ REPLAGAL ® (AGALSIDASE ALFA GHU) 1 MG/ML CONCENTRATED INJECTION VIAL CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about REPLAGAL. It does not contain all of the available information. Reading this leaflet does not take the place of talking to your doctor or pharmacist. Please read this leaflet before you start taking REPLAGAL. All medicines have risks and benefits. Your doctor has weighed the possible risks of taking REPLAGAL against the expected benefits. If you have any concerns about taking REPLAGAL, ask your doctor or pharmacist. Keep this leaflet. You may want to read it again. WHAT IS REPLAGAL USED FOR REPLAGAL is used to treat Fabry Disease. REPLAGAL is given as enzyme replacement therapy when the level of enzyme in the body is lower than normal as in Fabry Disease. Agalsidase alfa is a form of the human enzyme α-galactosidase A. It is produced by switching on the gene for α-galactosidase A in cells. The enzyme is then removed from the cells and made into a sterile concentrate for solution for infusion. Before REPLAGAL is given to you, it is mixed with 0.9% sodium chloride intravenous solution (saline). The prepared solution will be infused into a vein in your arm over a 40 minute period. Your doctor may have prescribed REPLAGAL for another use. Ask your doctor if you have any questions about why REPLAGAL has been prescribed for you. REPLAGAL is not addictive. REPLAGAL is not expected to affect your ability to drive a car or operate machinery. REPLAGAL is only available on a doctor’s prescription. BEFORE YOU TAKE REPLAGAL _WHEN YOU MUST NOT USE IT _ Do not use REPLAGAL if: • You are allergic (hypersensitive) to agalsidase alfa or a Baca dokumen lengkapnya